Anny
Lv1
10 积分
2023-12-13 加入
-
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial
2个月前
已完结
-
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial
2个月前
已完结
-
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial
2个月前
已完结
-
Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications
6个月前
已完结
-
Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications
6个月前
已完结
-
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells
6个月前
已完结
-
Laminated Solar Thin Glass Mirror Solution for Cost Effective CSP Systems
6个月前
已关闭
-
Perioperative treatment strategies in EGFR-mutant early-stage NSCLC: current evidence and future challenges
8个月前
已完结
-
In Vivo CAR Monocytes Show Efficacy in Mice
8个月前
已完结
-
How can we improve the quality of data collected in general practice?
10个月前
已完结